{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:45:17Z","timestamp":1761741917139},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1006\/pupt.2001.0315","type":"journal-article","created":{"date-parts":[[2002,9,25]],"date-time":"2002-09-25T18:55:31Z","timestamp":1032980131000},"page":"7-15","source":"Crossref","is-referenced-by-count":13,"title":["Modulation of TNF and GM-CSF Release from Dispersed Human Nasal Polyp Cells and Human Whole Blood by Inhibitors of Different PDE Isoenzymes and Glucocorticoids"],"prefix":"10.1006","volume":"15","author":[{"given":"Degenhard","family":"Marx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Tassabehji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Heer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.-B.","family":"H\u00fcttenbrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istvan","family":"Szelenyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/pupt.2001.0315_RF1","first-page":"724","article-title":"Biology of disease- biologic activities and mechanisms of action of tumor necrosis factor \u03b1\/cachectin","volume":"64 (6)","author":"J\u00e4\u00e4ttel\u00e4","year":"1991","journal-title":"Laboratory Investig"},{"key":"10.1006\/pupt.2001.0315_RF2","first-page":"255","article-title":"Potential of phosphodiesterase type 4 inhibitors in the treatment of rheumatoid arthritis","volume":"2","author":"Souness","year":"1998","journal-title":"Curr Res Rheum Arthrit"},{"key":"10.1006\/pupt.2001.0315_RF3","first-page":"420","article-title":"SB 207499 (Ariflo\u2122), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro antiinflammatory actions","volume":"284","author":"Barnette","year":"1998","journal-title":"J, Pharmacol Exp Ther"},{"key":"10.1006\/pupt.2001.0315_RF4","first-page":"A","article-title":"The therapeutic activity of SB 207499 (Ariflo\u2122), a second-generation phosphodiesterase 4 inhibitor, is equivalent to that of prednisolone in models of pulmonary inflammation","volume":"157","author":"Underwood","year":"1998","journal-title":"Am J, Respir Crit Care Med"},{"key":"10.1006\/pupt.2001.0315_RF5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2222.1999.00018.x","article-title":"Selective phosphodiesterase inhibitors for the treatment of bronchial asthma and chronic obstructive pulmonary disease","volume":"29","author":"Schmidt","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1006\/pupt.2001.0315_RF6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2249.1990.tb03334.x","article-title":"Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine","volume":"81","author":"MacDonald","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1006\/pupt.2001.0315_RF7","first-page":"359","article-title":"Established and emerging biological activity markers of inflammatory bowel disease","volume":"95","author":"Nielsen","year":"2000","journal-title":"Am J, Gastroenterol"},{"key":"10.1006\/pupt.2001.0315_RF8","first-page":"22","article-title":"Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice","volume":"292","author":"Hartmann","year":"2000","journal-title":"J, Pharmacol Exp Ther"},{"key":"10.1006\/pupt.2001.0315_RF9","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1365-2222.1995.tb03249.x","article-title":"Tumor necrosis factor alpha: a potential mediator of asthma","volume":"25","author":"Shah","year":"1995","journal-title":"Clin Experim Allergy"},{"key":"10.1006\/pupt.2001.0315_RF10","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.153.5.2278","article-title":"TNF\u03b1 production by eosinophils in upper airways inflammation (nasal polyposis)","volume":"153","author":"Finotto","year":"1994","journal-title":"J, Immunol"},{"key":"10.1006\/pupt.2001.0315_RF11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2222.1995.tb01071.x","article-title":"TNF\u03b1 is localized to nasal mast cells and is released in acute allergic rhinitis","volume":"25","author":"Bradding","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"10.1006\/pupt.2001.0315_RF12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1165\/ajrcmb.17.2.2722","article-title":"Inability of histamine to regulate TNF\u03b1 production by human alveolar macrophages","volume":"17","author":"Rowe","year":"1997","journal-title":"Am J, Respir Cell Mol Biol"},{"key":"10.1006\/pupt.2001.0315_RF13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF01993235","article-title":"Cytokine production in whole blood ex vivo","volume":"34","author":"Finch-Arietta","year":"1991","journal-title":"Agents and Actions"},{"key":"10.1006\/pupt.2001.0315_RF14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0006-291X(91)90478-P","article-title":"Kinetics of TNF, IL-6 and IL-8 gene expression in LPS-stimulated human whole blood","volume":"174","author":"De Forge","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1006\/pupt.2001.0315_RF15","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood.V77.6.1131.1131","article-title":"Molecular physiology of granulocyte-macrophage colony-stimulating factor (GM-CSF)","volume":"77 (6)","author":"Gasson","year":"1991","journal-title":"Blood"},{"key":"10.1006\/pupt.2001.0315_RF16","first-page":"1668","article-title":"Interleukin 11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR-cells and synergises with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor","volume":"21","author":"Lemoli","year":"1993","journal-title":"Exp Hematol"},{"key":"10.1006\/pupt.2001.0315_RF17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0090-1229(90)90047-T","article-title":"Granulocyte-macrophage colony-stimulating factor: more than a hemopoietin","volume":"54","author":"Monroy","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1006\/pupt.2001.0315_RF18","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1182\/blood.V77.12.2694.2694","article-title":"Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony-stimulating factor and interleukin-3","volume":"77","author":"Warringa","year":"1991","journal-title":"Blood"},{"key":"10.1006\/pupt.2001.0315_RF19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1378\/chest.105.3.687","article-title":"Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients. Relationship to atopic status, symptoms, and level of airway hyperresponsiveness","volume":"105","author":"Ackerman","year":"1994","journal-title":"Chest"},{"key":"10.1006\/pupt.2001.0315_RF20","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1557","article-title":"Detection of granulocyte-macrophage colony stimulating factor in asthmatic bronchial epithelium and decrease by inhaled steroids","volume":"147","author":"Sousa","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1006\/pupt.2001.0315_RF21","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0091-6749(94)90121-X","article-title":"Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthma","volume":"94","author":"Wang","year":"1994","journal-title":"J, Allergy Clin Immunol"},{"key":"10.1006\/pupt.2001.0315_RF22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1165\/ajrcmb.21.5.3694","article-title":"Calcium ionophore upregulation of AUUUA-specific binding protein activity is contemporaneous with granulocyte macrophage colony-stimulating factor messenger RNA stabilization in AML14.3D10 cells","volume":"21","author":"Ruth","year":"1999","journal-title":"Am J, Respir Cell Mol Biol"},{"key":"10.1006\/pupt.2001.0315_RF23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/sj.bjp.0700998","article-title":"Release of granulocyte-macrophage colony stimulating factor by human cultured airway smooth muscle cells: suppression by dexamethasone","volume":"120","author":"Saunders","year":"1997","journal-title":"Br J, Pharmacol"},{"key":"10.1006\/pupt.2001.0315_RF24","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1164\/ajrccm.151.6.7539326","article-title":"Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors","volume":"1551","author":"Lagente","year":"1995","journal-title":"Am J Crit Care Med"},{"key":"10.1006\/pupt.2001.0315_RF25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1136\/thx.46.7.512","article-title":"Phosphodiesterase inhibitors: New opportunities for the treatment of asthma","volume":"46","author":"Torphy","year":"1991","journal-title":"Thorax"},{"key":"10.1006\/pupt.2001.0315_RF26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1006\/pupt.1999.0182","article-title":"Therapeutic Potential of selective PDE Inhibitors in Asthma","volume":"12","author":"Schudt","year":"1999","journal-title":"Pulm Pharm Ther"},{"key":"10.1006\/pupt.2001.0315_RF27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/pupt.1999.0181","article-title":"Ariflo\u2122 (SB 207499), a second Generation Phosphodiesterase 4 inhibitor for the treatment of Asthma and COPD: from Concept to Clinic","volume":"12","author":"Torphy","year":"1999","journal-title":"Pulm Pharm Ther"},{"key":"10.1006\/pupt.2001.0315_RF28","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1517\/13543784.8.9.1301","article-title":"The therapeutic potential of PDE4 inhibitors","volume":"8","author":"Dyke","year":"1999","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1006\/pupt.2001.0315_RF29","first-page":"111","article-title":"Interaction of PDE4 inhibitors with enzymes and cell functions","author":"Dent","year":"1996"},{"key":"10.1006\/pupt.2001.0315_RF30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0022-1759(91)90193-J","article-title":"A convenient human whole blood culture system for studying the regulation of tumor necrosis factor release by bacterial lipopolysaccharide","volume":"139","author":"Wilson","year":"1991","journal-title":"J, Immunol Methods"},{"key":"10.1006\/pupt.2001.0315_RF31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1365-2222.1995.tb01104.x","article-title":"Nasal polyps- a model of chronic respiratory mucosal inflammation (editorial)","volume":"25","author":"Djukanovic","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"10.1006\/pupt.2001.0315_RF32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1165\/ajrcmb\/6.1.37","article-title":"Histochemical and immunohistochemical characteristics of mast cells in nasal polyps","volume":"6","author":"Kawabori","year":"1992","journal-title":"Am J, Respir Cell Mol Biol"},{"key":"10.1006\/pupt.2001.0315_RF33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1017\/S002221510012331X","article-title":"Mast cell quantitation in nasal polyps, sinus mucosa and nasal turbinate mucosa","volume":"107","author":"Otsuka","year":"1993","journal-title":"J, Laryngol Otol"},{"key":"10.1006\/pupt.2001.0315_RF34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0091-6749(93)90267-J","article-title":"Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study","volume":"91","author":"Stoop","year":"1993","journal-title":"J, Allergy Clin Immunol"},{"key":"10.1006\/pupt.2001.0315_RF35","first-page":"125","article-title":"Immunocompetent cells in human nasal polyps and normal mucosa","volume":"31","author":"Linder","year":"1993","journal-title":"Rhinology"},{"key":"10.1006\/pupt.2001.0315_RF36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000236468","article-title":"Anti-allergic activity of H1-blockers","volume":"101","author":"Campbell","year":"1993","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1006\/pupt.2001.0315_RF37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0192-0561(93)90052-Z","article-title":"The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells","volume":"15","author":"Semmler","year":"1993","journal-title":"Int J, Immunopharmacol"},{"key":"10.1006\/pupt.2001.0315_RF38","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/0006-2952(92)90160-K","article-title":"Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?","volume":"43","author":"Giembycz","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1006\/pupt.2001.0315_RF39","first-page":"51","article-title":"Biochemical characteristics and cellular regulation of phosphodiesterase IV","volume":"43","author":"Torphy","year":"1993","journal-title":"Agents Actions"},{"key":"10.1006\/pupt.2001.0315_RF40","first-page":"212A","article-title":"LPS-induced tumor necrosis factor alpha release by isolated human monocytes is sensitive to agents that elevate intracellular levels of cyclic AMP","volume":"150","author":"Cohan","year":"1993","journal-title":"J, Immunol"},{"key":"10.1006\/pupt.2001.0315_RF41","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1476-5381.1996.tb15450.x","article-title":"Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a \u2018low-affinity\u2019 phosphodiesterase 4 conformer","volume":"118","author":"Souness","year":"1996","journal-title":"Br J, Pharmacol"},{"key":"10.1006\/pupt.2001.0315_RF42","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0006-2952(96)00053-6","article-title":"Association of the antiinflammatory activity of phosphodiesterase 4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [3H]rolipram binding","volume":"51","author":"Barnette","year":"1996","journal-title":"Biochem. Pharmacol"},{"key":"10.1006\/pupt.2001.0315_RF43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0014-5793(89)81016-6","article-title":"Interactions of formylmethionyl-leucyl-phenylalanine, adenosine, and phosphodiesterase inhibitors in human monocytes: effects on superoxide release, inositol phosphates and cAMP","volume":"254","author":"Elliott","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1006\/pupt.2001.0315_RF44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2222.1995.tb01110.x","article-title":"Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages","volume":"25","author":"Tenor","year":"1995","journal-title":"Clin Exp Allergy"},{"key":"10.1006\/pupt.2001.0315_RF45","first-page":"1164","article-title":"Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isoenzymes in human monocytic cells","volume":"47","author":"Verghese","year":"1995","journal-title":"Mol Pharmacol Ther"},{"key":"10.1006\/pupt.2001.0315_RF46","first-page":"L694","article-title":"Phosphodiesterase expression in human epithelial cells","volume":"275","author":"Wright","year":"1998","journal-title":"Am J, Physiol"},{"key":"10.1006\/pupt.2001.0315_RF47","doi-asserted-by":"crossref","first-page":"C77","DOI":"10.1007\/BF01972726","article-title":"Modulation of TNF\u03b1 and IL-1\u03b2 from endotoxin-stimulated monocytes by selective PDE isoenzyme inhibitors","volume":"39","author":"Molnar-Kimber","year":"1993","journal-title":"Agents Actions"},{"key":"10.1006\/pupt.2001.0315_RF48","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1476-5381.1996.tb16030.x","article-title":"The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation","volume":"119","author":"Banner","year":"1996","journal-title":"Br J, Pharmacol"},{"key":"10.1006\/pupt.2001.0315_RF49","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0165-6147(93)90184-L","article-title":"Antiinflammatory actions of steroids: molecular mechanisms","volume":"14","author":"Barnes","year":"1993","journal-title":"Trends Pharmacol Sci"},{"key":"10.1006\/pupt.2001.0315_RF50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF02311086","article-title":"Modulation of tumor necrosis factor (TNF) receptor expression during monocytic differentiation by glucocorticoids","volume":"45","author":"Goppelt-Struebe","year":"1996","journal-title":"Inflamm Res"},{"key":"10.1006\/pupt.2001.0315_RF51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0954-6111(95)90259-7","article-title":"Fluticasone propionate an update on preclinical and clinical experience","volume":"89 (suppl A)","author":"Fuller","year":"1995","journal-title":"Respir Med"},{"key":"10.1006\/pupt.2001.0315_RF52","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1164\/ajrccm\/154.2_Pt_2.S21","article-title":"Mechanisms of action of glucocorticoids in asthma","volume":"154","author":"Barnes","year":"1996","journal-title":"Am J, Respir Crit Care Med"},{"key":"10.1006\/pupt.2001.0315_RF53","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1164\/ajrccm\/154.2_Pt_2.S58","article-title":"Steroid Resistance in Asthma","volume":"154","author":"Adcock","year":"1996","journal-title":"Am J, Respir Crit Care Med"},{"key":"10.1006\/pupt.2001.0315_RF54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0091-6749(99)70529-4","article-title":"Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression, and proinflammatory cytokine mRNA in nasal polyp disease","volume":"103","author":"Hamilos","year":"1999","journal-title":"J, Allergy Clin Immunol"},{"key":"10.1006\/pupt.2001.0315_RF55","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/107999099313253","article-title":"Effect of prednisolone on cytokine synthesis in nasal polyps","volume":"19","author":"Rudack","year":"1999","journal-title":"J, Interferon Cytokine Res"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553901903153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553901903153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T06:44:05Z","timestamp":1680590645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553901903153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S1094553901903153"],"URL":"https:\/\/doi.org\/10.1006\/pupt.2001.0315","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}